CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2 KEY BENEFITS

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rising geriatric population base
3.6.1.2. Demand of HAI diagnostics from middle and low-income countries
3.6.1.3. Development of technologically advanced diagnostic products

3.6.2. Restraints

3.6.2.1. Decreasing prevalence of nosocomial infections in the developed countries
3.6.2.2. Lack of awareness regarding HAI

3.6.3. Opportunities

3.6.3.1. Introduction of awareness programs by various organizations

CHAPTER 4 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. INSTRUMENT

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. REAGENTS AND CONSUMABLES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. MOLECULAR DIAGNOSTICS

5.2.1. Market size and forecast

5.3. IMMUNOASSAY

5.3.1. Market size and forecast

5.4. URINALYSIS

5.4.1. Market size and forecast

CHAPTER 6 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DISEASE TESTING

6.2.1. Market size and forecast

6.3. DRUG-RESISTANCE TESTING

6.3.1. Market size and forecast

CHAPTER 7 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. HOSPITAL ACQUIRED PNEUMONIA

7.2.1. Market size and forecast

7.3. BLOODSTREAM INFECTIONS

7.3.1. Market size and forecast

7.4. SURGICAL SITE INFECTIONS

7.4.1. Market size and forecast

7.5. GASTROINTESTINAL INFECTIONS

7.5.1. Market size and forecast

7.6. URINARY TRACT INFECTIONS (UTI)

7.6.1. Market size and forecast

7.7. OTHERS

7.7.1. Market size and forecast

CHAPTER 8 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. HOSPITALS

8.2.1. Market size and forecast

8.3. CLINICS

8.3.1. Market size and forecast

8.4. AMBULATORY SURGERY CENTERS

8.4.1. Market size and forecast

8.5. OTHERS

8.5.1. Market size and forecast

CHAPTER 9 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY GEOGRAPHY

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. NORTH AMERICA

9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.2.4. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.5. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.6. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.7. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.2.8.1. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.2. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.3. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.4. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.5. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.2.8.6. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.7. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.8. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.9. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.10. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.2.8.11. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.12. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.13. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.14. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.15. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.3. EUROPE

9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.3.4. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.5. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.6. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.7. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.3.8.1. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.2. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.3. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.4. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.5. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.6. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.7. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.8. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.9. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.10. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.11. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.12. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.13. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.14. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.15. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.16. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.17. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.18. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.19. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.20. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.21. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.22. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.23. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.24. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.25. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.26. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.27. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.28. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.29. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.30. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.4. ASIA-PACIFIC

9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.4.4. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.5. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.6. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.7. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.4.8.1. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.2. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.3. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.4. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.5. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.6. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.7. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.8. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.9. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.10. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.11. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.12. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.13. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.14. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.15. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.16. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.17. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.18. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.19. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.20. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.21. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.22. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.23. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.24. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.25. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.26. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.27. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.28. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.29. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.30. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.5. LAMEA

9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.5.4. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.5. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.6. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.7. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.5.8.1. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.2. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.3. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.4. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.5. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.6. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.7. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.8. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.9. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.10. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.11. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.12. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.13. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.14. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.15. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.16. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.17. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.18. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

CHAPTER 10 COMPANY PROFILES

10.1. ABBOTT LABORATORIES

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Business performance
10.1.5. Key strategic moves and developments

10.2. ADVAN DX

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Key strategic moves and developments

10.3. ALERE INC.

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Business performance
10.3.5. Key strategic moves and developments

10.4. ASTRAZENECA PLC

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Key strategic moves and developments

10.5. BAYER SCHERING PHARMA LLC

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Key strategic moves and developments

10.6. BECTON DICKINSON AND COMPANY

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Key strategic moves and developments

10.7. CEPHEID INC.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Key strategic moves and developments

10.8. ROCHE AG

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Key strategic moves and developments

10.9. DAIICHI SANKYO

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Business performance
10.9.5. Key strategic moves and developments

10.10. HOLOGIC, INC.

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Key strategic moves and developments